Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Bovie Medical Corporation Announces 510K Submission To The FDA For Its BOSS Soft Tissue Coagulation Device
Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, announced a 510K submission to the FDA seeking pre-market clearance for Bovie"s BOSS for surgical applications where soft tissue bipolar coagulation is desired. The BOSS is the latest generation device based on Bovie"s saline enhanced sintered steel technology.

New Broad-Spectrum Vaccine To Prevent Cervical Cancer Induces Strong Responses In Animals
Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute.
News of the day
Spectranetics Announces First Human Uses Of Turbo-Tandem™ System
Spectranetics Corporation (Nasdaq: SPNC) reported the first human procedures using its Turbo-Tandem™ System, which had earlier received FDA clearance and CE mark approval for marketing in the US and the EU. The Turbo-Tandem System is a single-use, disposable device indicated for atherectomy of infrainguinal arteries. It is comprised of two integrated catheters, a 7 French laser guide catheter in combination with a 2.0mm excimer laser ablation catheter, and is designed to perform atherectomy and ablation of plaque in arterial lesions above the knee, primarily within the superficial femoral and popliteal arteries.
Endocrinology

To Lead The Transformation Of Health Care, Young Physicians Selected For Prestigious National Fellowship

The Robert Wood Johnson Foundation Clinical Scholars Program® is pleased to announce the selection of 29 young physicians who will learn to conduct innovative research and work with communities, organizations, practitioners and policy-makers on issues important to the health and well-being of all Americans. They will begin their prestigious two-year fellowships in July 2010. "Clinical Scholars are leading change through every level of the health care system including community practice, local and state government, the federal government, and professional organizations," said Desmond K. Runyan, M.D., Dr.P.H., national program director for the Clinical Scholars Program. The new Clinical Scholars are outstanding young physicians who were selected competitively from applicants enrolled in medical and surgical residencies across the United States. Scholars conduct research in diverse, health-related fields such as health care delivery and financing, clinical decision-making, biomedical ethics, and health care policy. The program also includes leadership training and engagement in community-based, participatory research. Clinical Scholars receive their training at one of four universities: Yale University, the University of Pennsylvania, the University of Michigan, or the University of California, Los Angeles. Through the program scholars will spend two years examining the delivery, impact and organization of health care. This background will help prepare them to lead efforts to transform health care in this country through positions in academic medicine, public health and other leadership roles. They join a distinguished group of over 1,100 alumni who include prominent leaders of public and private agencies at the state and national levels, five public health and medical school deans, 40 Institute of Medicine members, 19 medical school department chairs, over 100 vice chairs of departments or division chiefs, and numerous medical school professors. This training program, established in 1969 and supported by the Robert Wood Johnson Foundation since 1972, is one of the oldest and most prestigious fellowships awarded to physicians. The Department of Veterans Affairs will be a partner supporting nine of the 29 Scholars. Desmond Runyan, M.D., Dr.P.H. IQ Solutions, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009